RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
  Dialysis
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
Research Article
Dialysis Channel

subscribe to Dialysis newsletter
Latest Research : Nephrology : Dialysis

   EMAIL   |   PRINT
Lower death rate in dialysis patients living at higher altitude

Feb 3, 2009 - 11:16:02 PM , Reviewed by: Dr. Sanjukta Acharya

 
[RxPG] Compared to dialysis patients living near sea level, dialysis patients living at an altitude higher than 4,000 feet have a 12-15 percent lower rate of death, according to a study in the February 4 issue of JAMA.

A recent study found that patients with end-stage renal (kidney) disease (ESRD) living at higher altitude achieved greater hemoglobin concentrations (a protein in red blood cells that primarily transports oxygen from the lungs to the rest of the body) while receiving lower doses of erythropoietin (a hormone that stimulates the production of red blood cells). Increased iron availability caused by activation of hypoxia-induced (oxygen deficiency) factors at higher altitude may explain this finding, according to background information in the article.

Wolfgang C. Winkelmayer, M.D., Sc.D., of Brigham and Women's Hospital and Harvard Medical School, Boston, and colleagues examined whether increased altitude would be associated with a reduced rate of death for patients initiating chronic dialysis. Using a comprehensive dialysis registry, the researchers identified 804,812 patients with ESRD who initiated dialysis between 1995 and 2004 and who met the study entry requirements. Most patients resided below an altitude of 250 ft. (40.5 percent) or between 250-1,999 ft. (54.4 percent). Only 1.9 percent of incident dialysis patients lived between 4,000 and 5,999 ft. and 0.4 percent higher than 6,000 ft. Patients were stratified by the average elevation of their residential zip code.

Compared with patients living at lower altitudes (less than 250 ft.), the rate of death was reduced for patients living from 250-1,999 ft. by 3 percent; from 2,000 through 3,999 ft. by 7 percent; from 4,000 to 5,999 ft. by 12 percent; and higher than 6,000 ft. by 15 percent.

Actuarial 5-year survival was 34.8 percent for patients living at or near sea level but was 42.7 percent among those living at an altitude higher than 6,000 ft.; patients in the highest elevation group experienced a 7.9 percent greater absolute or 22.7 percent greater relative 5-year survival. Median (midpoint) survival after initiation of dialysis was 3.1 years for those living lower than 250 ft. but was 4.0 years for those living at an altitude higher than 6,000 ft., for a difference in median survival of 0.9 years between these 2 groups.

While a decrease in age- and sex-standardized mortality at higher altitude was also observed in the general population, the magnitude of the risk reduction was half of that observed in the ESRD population.

"In conclusion, we found a graded reduction in mortality from any cause in ESRD patients residing at greater altitude, a finding that was not explained by differences in observed patient characteristics. The magnitude of this observation was markedly greater than the observed small reduction in mortality at higher altitude in the general population. We propose that hypoxia-inducible factors are persistent at high altitude in patients with ESRD and may confer protective effects," the authors write.



Publication: February 4 issue of JAMA

Advertise in this space for $10 per month. Contact us today.


Related Dialysis News
Intradialytic hypotension associated with increased incidence of haemodialysis vascular access thrombosis
Low Phosphate diet not helpful in dialysis patients
Nephrologist care prior to starting dialysis reduces risk of death
Lower death rate in dialysis patients living at higher altitude
Clear advantage of high efficacy Haemodiafiltration over conventional hemodialysis
Dialysis patients may be overmedicated
Dialysis patients often have close family members also on dialysis - Study
Hemodialysis causes antioxidant loss leading to long-term complications
Oxidative Stress in Dialysis Patients can Lead to Long-Term Health Problems

Subscribe to Dialysis Newsletter

Enter your email address:


 About Dr. Sanjukta Acharya
This news story has been reviewed by Dr. Sanjukta Acharya before its publication on RxPG News website. Dr. Sanjukta Acharya, MBBS MRCP is the chief editor for RxPG News website. She oversees all the medical news submissions and manages the medicine section of the website. She has a special interest in nephrology. She can be reached for corrections and feedback at sanjukta.acharya@rxpgnews.com
RxPG News is committed to promotion and implementation of Evidence Based Medical Journalism in all channels of mass media including internet.
 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)